GE Medical Systems last month increased its growing investmentin the equipment maintenance sector by agreeing to acquire twocompanies that market service-related products. GE bought theU.S. healthcare insurance business of Specialty Underwriters ofOak
GE Medical Systems last month increased its growing investmentin the equipment maintenance sector by agreeing to acquire twocompanies that market service-related products. GE bought theU.S. healthcare insurance business of Specialty Underwriters ofOak Creek, WI, as well as independent service organization MaintenanceManagement, which is a subsidiary of Specialty Underwriters.
Specialty Underwriters offers healthcare maintenance insurance,in which an insurer covers a healthcare facility and pays forthe costs of equipment repair and maintenance, much as individualindemnity insurance plans do. Maintenance Management specializesin biomedical service, according to Gary Foster, GE's generalmanager of service marketing. The acquisition adds niche productsand services to GE's multivendor service business.
"It will continue our emphasis on having the broadest arrayof products for our customers," Foster said.
Both businesses were founded and owned by Michael Polaski, whowill continue to operate the non-healthcare operations of SpecialtyUnderwriters, as well as the company's healthcare maintenanceinsurance operations outside the U.S.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.